Amgen-23

CAS No. 1448706-15-7

Amgen-23( —— )

Catalog No. M35699 CAS No. 1448706-15-7

Amgen-23 is a selective and highly potent sphingosine kinase 1 (SPHK1) inhibitor that inhibits SPHK2 and can be used in anticancer research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 206 In Stock
5MG 188 In Stock
10MG 313 In Stock
25MG 565 In Stock
50MG 857 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Amgen-23
  • Note
    Research use only, not for human use.
  • Brief Description
    Amgen-23 is a selective and highly potent sphingosine kinase 1 (SPHK1) inhibitor that inhibits SPHK2 and can be used in anticancer research.
  • Description
    Amgen-23 (compound 23) is a potent sphingosine kinases (SPHK) inhibitor with IC50 values of 20 nM and 1.6 μM for SPHK1 and SPHK2, respectively. Amgen-23 can be used for researching anticancer.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    S1P Receptor
  • Recptor
    S1P Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1448706-15-7
  • Formula Weight
    478.44
  • Molecular Formula
    C23H25Cl2N3O2S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (209.02 mM; Ultrasonic )
  • SMILES
    N(C1=NC(=CS1)C2=CC(Cl)=C(Cl)C=C2)C3=CC=C(CCN4[C@@H](CO)C[C@@H](O)CC4)C=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Gustin DJ, et al. Structure guided design of a series of sphingosine kinase (SphK) inhibitors. Bioorg Med Chem Lett. 2013 Aug 15;23(16):4608-16.?
molnova catalog
related products
  • PF429242 dihydrochlo...

    PF429242 dihydrochloride can reversibly inhibit S1P (IC50 of 175 nM).

  • JTE-013

    JTE-013 is an effective and specific antagonist of S1P2. JTE-013 suppresses the specific binding of radiolabeled S1P to human and rat S1P2 (IC50s: 17 nM and 22 nM, respectively).JTE-013 is a S1P2 antagonist. JTE-013 (50-200 μM;?1-3 days) decreased cell viability.

  • PF-543 hydrochloride

    PF-543 inhibits SphK1 with a K(i) of 3.6 nM, is sphingosine-competitive and is more than 100-fold selective for SphK1 over the SphK2 isoform.